Detection of plasma cells, C4d deposits and donor-specific antibodies on sequential graft biopsies of renal transplant recipients with chronic dysfunction

Transplant Immunology

Volumn 22, Issue 3-4, 2010, Pages 110-114

  Martin, Laurent ^a,e   Charon Barra, Céline ^a   Bocrie, Olivier ^e   Guignier, Fredy ^b,e   D'Athis, Philippe ^d   Dautin, Guillaume ^b,e   de la Vega, Mathilde Funes ^a   Justrabo, Eve ^a,e   Rifle, Gérard ^c,e   Mousson, Christiane ^c,e  

^a PTB   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c DIJON UNIVERSITY HOSPITAL   (France)

^d School of Medicine   (France)

^e IFR No 100   (France)

Author keywords

Anti HLA antibodies; C4d deposits; Chronic allograft rejection; Complement; Kidney transplantation; Plasma cells

Indexed keywords

COMPLEMENT COMPONENT C4D; HLA ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL ARTICLE; COMPLEMENT DEPOSITION; CONTROLLED STUDY; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMORAL IMMUNITY; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MONONUCLEAR CELL; PLASMA CELL; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

BIOPSY; CELL COUNT; CHRONIC DISEASE; COMPLEMENT C4B; DELAYED GRAFT FUNCTION; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HLA ANTIGENS; HUMANS; IMMUNE COMPLEX DISEASES; ISOANTIBODIES; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PLASMA CELLS;

EID: 77951651996     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2009.11.001     Document Type: Article

References (35)

1. Racusen L.C., Colvin R.B., Solez K., Mihatsch M.J., Halloran P.F., Campbell P.M., et al. Antibody-mediated rejection criteria- an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003, 3:708-714.
2. Solez K., Colvin R.B., Racusen L.C., Sis B., Halloran P.F., Birk P.E., et al. Banff '05 meeting report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007, 7:518-526.
3. McKenna R.M., Takemoto S., Terasaki P.I. Anti-HLA antibodies after solid organ transplantation. Transplantation 2000, 69:319-326.
4. Terasaki P.I. Humoral theory of transplantation. Am J Transplant 2003, 3:665-673.
5. Rifle G., Mousson C., Martin L., Guignier F., Hajji K. Donor-specific antibodies in allograft rejection: clinical and experimental data. Transplantation 2005, 79:S14-S18.
6. Stegall M.D., Dean P.G., Gloor J. Mechanisms of alloantibody production in sensitized renal allograft recipients. Am J Transplant 2009, 9:998-1005.
7. Thaunat O., Field A.C., Dai J., Louedec L., Patey N., Bloch M.F., et al. Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response. Proc Natl Acad Sc USA 2005, 102:14723-14728.
8. Martin L., Guignier F., Mousson C., Rageot D., Justrabo E., Rifle G. Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and serums from renal transplant recipients with chronic allograft nephropathy. Transplantation 2003, 76:395-400.
9. Martin L., Guignier F., Bocrie O., D'Athis P., Rageot D., Rifle G., et al. Detection of anti-HLA antibodies by flow cytometry in eluates from needle core biopsies of renal transplant recipients with chronic allograft nephropathy. Transplantation 2005, 79:1459-1461.
10. Bocrie O., Hussein Aly A.A., Guignier F., Funes de la Vega M., Rifle G., Mousson C., et al. Distribution of donor-specific antibodies in the cortex and the medulla of renal transplants with chronic allograft nephropathy. Transplant Immunol 2007, 17:227-229.
11. Bray R.A. Flow cytometry cross-matching for solid organ transplantation. Methods Cell Biol 1994, 41:103-119.
12. Feucht H.E., Felbert E., Gokel M.J., Hillebrand G., Nattermann U., Brockmeyer C., et al. Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection. Clin Exp Immunol 1991, 86:464-470.
13. Feucht H.E., Schneeberg H., Hillebrand G., Burkhardt K., Weiss M., Riethmuller G., et al. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 1993, 43:1333-1338.
14. Collins A.B., Schneeberger E.E., Pascual M.A., Saidman S.L., Williams W.W., Tolkoff-Rubin N., et al. Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 1999, 10:2208-2214.
15. Crespo M., Pascual M., Tolkoff-Rubin N., Mauiyyedi S., Collins A.B., Fitzpatrick D., et al. Acute humoral rejection in renal allograft recipients. I. Incidence, serology and clinical characteristics. Transplantation 2001, 71:652-658.
16. Mauiyyedi S., Crespo M., Collins A.B., Schneeberger E.E., Pascual M.A., Saidman S.L., et al. Acute humoral rejection in kidney transplantation: II. morphology, immunopathology and pathologic classification. J Am Soc Nephrol 2002, 13:779-787.
17. Mauiyyedi S., Della Pelle P., Saidman A., Collins A.B., Pascual M., Tolkoff-Rubin N.E., et al. Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 2001, 12:574-582.
18. Herzenberg A.M., Gill J.S., Djurdjev O., Magil A.B. C4d deposition in acute rejection: an independent long-term prognostic factor. J Am Soc Nephrol 2002, 13:234-241.
19. Kuypers D.R., Lerut E., Evenepoel P., Maes B., Vanrenterghem Y., Van Damme B. C3d deposition in peritubular capillaries indicates a variant of acute renal allograft rejection characterized by a worse clinical outcome. Transplantation 2003, 76:102-108.
20. Charney D.A., Nadasdy T., Lo W.H., Racusen L.C. Plasma cell-rich acute renal allograft rejection. Transplantation 1999, 68:791-797.
21. Meehan S.M., Domer P., Josephson M., Donoghue M., Sadhu A., Ho L.T., et al. The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies. Hum Pathol 2001, 32:205-215.
22. Desvaux D., Le Gouvello S., Pastural M., Abtahi M., Suberbielle C., Boeri N., et al. Acute renal allograft rejections with major-interstitial oedema and plasma cell-rich infiltrates: high gamma-interferon expression and poor clinical outcome. Nephrol Dial Transplant 2004, 19:933-939.
23. Gartner V., Eigentler T.K., Viebhan R. Plasma cell-rich rejection processes in renal transplantation: morphology and prognostic relevance. Transplantation 2006, 81:986-991.
24. Xu X., Shi B., Cai M., Han Y., Wang Q., Xu L., et al. A retrospective study of plasma cell infiltrates in explanted renal allografts. Transplant Proc 2008, 40:1366-1370.
25. Einecke G., Reeve J., Mengel M., Sis B., Bunnag S., Mueller T.F., Halloran P.F. Expression of B cell and immunoglobulin transcripts is a feature of inflammation in late allografts. Am J Transplant 2008, 8:1434-1443.
26. Cramer D.V., Shirwan H. The importance of humoral immune responses in chronic rejection. Transplantation Rev 1998, 12:166-176.
27. Lachmann N., Terasaki P., Budde K., Liefeldt L., Kalh A., Reinke P., et al. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex post-transplant serve as biomarkers for chronic rejection of renal allografts. Transplantation 2009, 87:1505-1513.
28. Nadasdy T., Krenacs T., Kalmar K.N., Csajbok E., Boda K., Ormos J. Importance of plasma cells in the infiltrate of renal allografts. An immunohistochemical study. Pathol Res Pract 1991, 187:178-183.
29. Suciu-Foca N., Reed E., D'Agati V.D., Ho E., Cohen D.J., Benvenisty A.I., et al. Soluble HLA antigens, anti-HLA antibodies, and antiidiotypic antibodies in the circulation of renal transplant recipients. Transplantation 1991, 51:593-601.
30. Piazza A., Torlone N., Valeri M., Poggi E., Monaco P.I., Provenzani L., et al. Antidonor-HLA antibodies and soluble HLA antigens after kidney transplant. Transplant Proc 1993, 25:3279-3280.
31. Jindra P.T., Zhang X., Mulder A., Claas F., Veale J., Jin Y.P., et al. Anti-HLA antibodies can induce endothelial cell survival or proliferation depending on their concentration. Transplantation 2006, 82:S33-S35.
32. Theruvath T.P., Saidman S.L., Mauiyyedi S., Delmonico F.L., Williams W.W., Tolkoff-Rubin N., et al. Control of anti-donor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection. Transplantation 2001, 72:77-83.
33. Nickeleit V., Zeiler M., Gudat F., Thiel G., Mihatsch M.J. Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications. J Am Soc Nephrol 2002, 13:242-251.
34. Snanoudj R., Beaudreuil S., Arzouk N., de Preneuf H., Durrbach A., Charpentier B. Immunological strategies targeting B cells in organ grafting. Transplantation 2005, 79:S33-S36.
35. Everly M.J., Everly J.J., Susskind B., Brailey P., Arend L.J., Alloway R.R., et al. Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection. Transplantation 2008, 86:1754-1761.